Crossref
Gut-lung axis in neonatal respiratory distress syndrome: integrated evidence from pharmacovigilance and Mendelian randomization
Journal of Chinese Pharmaceutical Sciences · 30.07.2026 · 35 (7) · 643
DOI: 10.5246/jcps.2026.07.046 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chinese Pharmaceutical Sciences, online erschienen am 10.07.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Gut-lung axis in neonatal respiratory distress syndrome: integrated evidence from pharmacovigilance and Mendelian randomization. Journal of Chinese Pharmaceutical Sciences, 35(7), 643. https://doi.org/10.5246/jcps.2026.07.046
Vancouver
Gut-lung axis in neonatal respiratory distress syndrome: integrated evidence from pharmacovigilance and Mendelian randomization. Journal of Chinese Pharmaceutical Sciences. 2026;35(7):643. doi:10.5246/jcps.2026.07.046
BibTeX
@article{euvimed2026,
title = {Gut-lung axis in neonatal respiratory distress syndrome: integrated evidence from pharmacovigilance and Mendelian randomization},
journal = {Journal of Chinese Pharmaceutical Sciences},
year = {2026},
volume = {35},
number = {7},
pages = {643},
doi = {10.5246/jcps.2026.07.046}
}
EUVIMED